Induction of interleukin-6 mRNA in rat alveolar macrophages by in vitro exposure to both Cryptococcus neoformans and anti-C. neoformans antiserum

Medical Mycology

Volumn 35, Issue 5, 1997, Pages 327-334

  Li, R K ^a,b   Mitchell, T G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

C. neoformans; induced IL 6 transcription; rat

Indexed keywords

ANTISERUM; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MESSENGER RNA; POLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; IN VITRO STUDY; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PHAGOCYTOSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

ANIMALS; CELLS, CULTURED; CRYPTOCOCCUS NEOFORMANS; IMMUNE SERA; INTERLEUKIN-6; KINETICS; MACROPHAGES, ALVEOLAR; MALE; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; POLYSACCHARIDES; RABBITS; RATS; RATS, INBRED LEW; RNA, MESSENGER; SPECIES SPECIFICITY; TIME FACTORS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030658898     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/02681219780001371     Document Type: Article

References (32)

1. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8: 515-548.
2. Bolafios B, Mitchell TG. Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum. J Leukoc Biol 1989; 46: 521-528. (Pubitemid 19275130)
3. Davies SF, Clifford DP, Hoidal JR, Repine JE. Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonuclear leukocytes and monocytes. J Infect Dis 1982; 145: 870-874. (Pubitemid 12088966)
4. Levitz SM, Dupont MP, Smail EH. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans. Infect Immun 1994; 62: 194-202. (Pubitemid 24011959)
5. Huffnagle GB, Lipscomb MF, Lovehik JA, et al. The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol 1994; 55: 35-42. (Pubitemid 24039583)
6. Mody CH, Chen GH, Jackson C, et al. Depletion of murine CD8+ T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans. J Lab Clin Med 1993; 121: 765-773. (Pubitemid 23175870)
7. Aguirre K, Havell EA, Gibson GW, Johnson LL. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect Immun 1995; 63: 1725-1731.
8. Cross CE, Bancroft GJ. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and β-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect Immun 1995; 63: 2604-2611.
9. Levitz SM, Tabuni A, Kornfeld H, et al. Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect Immun 1994; 62: 1975-1981. (Pubitemid 24137004)
10. Chen GH, Curtis JL, Mody CH, et al. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro. J Immunol 1994; 152: 724-734. (Pubitemid 24072976)
11. Levitz SM. Activation of human peripheral blood mononuclear cells by interleukin 2 and granulocyte-macrophage colony-stimulating factor to inhibit Cryptococcus neoformans. Infect Immun 1991; 59: 3393-3397.
12. Mukherjee J, Scharff MD, Casadevall A. Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains. Infect Immun 1995; 63: 3353-3359.
13. Mukherjee S, Feldmesser M, Casadevall A. J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. J Infect Dis 1996; 173: 1222-1231. (Pubitemid 26251467)
14. Goldman D, Lee SC, Casadevall A. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun 1994; 62: 4755-4761. (Pubitemid 24332772)
15. Muth SM, Murphy JW. Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice. Infect Immun 1995; 63: 1637-1644.
16. Sanford JE, Lupan DM, Schlageter AM, Kozel TR. Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with crypto-coccal polysaccharide. Infect Immun 1990; 58: 1919-1923. (Pubitemid 20176392)
17. Bolanos B, Mitchell TG. Killing of Cryptococcus neoformans by rat alveolar macrophages. J Med Vet Mycol 1989; 27: 219-228. (Pubitemid 19249537)
18. Bolanos B, Mitchell TG. Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages. J Med Vet Mycol 1989; 27: 203-217. (Pubitemid 19249536)
19. Small JM, Mitchell TG, Wheat RW. Strain variation in composition and molecular size of the capsular polysaccharide of Cryptococcus neoformans serotype A. Infect Immun 1986; 54: 735-741. (Pubitemid 17186444)
20. Kozel TR, Cazin J. Non-encapsulated variant of Cryptococcus neoformans. I. Virulence studies and characterization of soluble polysaccharide. Infect Immun 1971; 3: 287-294.
21. Savani DV, Perfect JR, Cobo LM, Durack DT. Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrob Agents Chemother 1987; 31: 6-10. (Pubitemid 17212647)
22. Maccani JE. Detection of cryptococcal polysaccharide using counterimmunoelectrophoresis. Am J Clin Pathol 1977; 68: 39-44.
23. Van Snick J. Interleukin 6; an overview. Annu Rev Immunol 1990; 8: 253-278.
24. Griffin FM. Roles of macrophage Fc and C3b receptors in phagocytosis of immunologically coated Cryptococcus neoformans. Proc Natl Acad Sci USA 1981; 78: 3853-3857.
25. Mukherjee S, Lee SC, Casadevall A. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect Immun 1995; 63: 573-579.
26. Mantovani B, Rabinovitch M, Nussenzweig V. Phagocytosis of immune complexes by macrophages. Different roles of the macrophage receptor sites for complement (C3) and for immunoglobulin (IgG). J Exp Med 1972; 135: 780-792.
27. Dromer F, Charreire J, Contrepois A, et al. Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect Immun 1987; 55: 749-752. (Pubitemid 17021971)
28. Blasi E, Barluzzi R, Mazzolla R, et al. Biomolecular events involved in anticryptococcal resistance in the brain. Infect Immun 1995; 63: 1218-1222.
29. Romani L, Mencacci A, Cenci E, et al. Impaired neutrophil response and CD4 + T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med 1996; 183: 1345-1355. (Pubitemid 26134278)
30. Mody CH, Tyler CL, Sitrin RG, et al. Interferon-gamma activates rat alveolar macrophages for anticryptococcal activity. Am J Respir Cell Mol Biol 1991; 5: 19-26.
31. Griffin JA, Griffin FM. Augmentation of macrophage complement receptor function in vitro. I. Characterization of the cellular interactions required for the generation of a T lymphocyte product that enhances macrophage complement receptor function. J Exp Med 1979; 150: 653-675. (Pubitemid 9250736)
32. Griffin FM, Griffin JA. Augmentation of macrophage complement receptor function in vitro. II. Characterization of the effects of a unique lymphokine upon the phagocytic capabilities of macrophages. J Immunol 1980; 125: 844-849. (Pubitemid 10045669)